InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Seidel-Dugan Cynthia, Directeur Scientifique. Insider active across 1 company, notably Werewolf Therapeutics, Inc.. In total, 1 disclosures have been published. Activity tracked since 12 January 2022. The latest transaction was filed on 12 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Cynthia Seidel-Dugan is the Chief Scientific Officer at Werewolf Therapeutics, Inc. She oversees research and development activities, ensuring that the company remains at the forefront of innovation in the therapeutic field. Her expertise is crucial for the scientific success of Werewolf Therapeutics.